Neutralizing SARS-CoV-2.

Poeschla, Eric

Poeschla, Eric.

Poeschla E; Division of Infectious Diseases, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, United States.

Elife ; 92020 12 15.

Article in English | MEDLINE | ID: covidwho-1344527

ABSTRACT

ABSTRACT

Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies.

Subject(s)

Antibodies, Monoclonal/immunology; Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; COVID-19/immunology; SARS-CoV-2/immunology; COVID-19/prevention & control; COVID-19/virology; COVID-19 Vaccines/administration & dosage; COVID-19 Vaccines/immunology; Evolution, Molecular; Humans; Mutation; RNA, Messenger/genetics; RNA, Messenger/immunology; RNA, Messenger/metabolism; SARS-CoV-2/genetics; SARS-CoV-2/physiology; Spike Glycoprotein, Coronavirus/immunology

Keywords

COVID-19; SARS-CoV-2; VSV; antibody; immunology; infectious disease; inflammation; microbiology; virus; viruses

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / Antibodies, Monoclonal / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: ELife.64496

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google